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ABSTRAK 
Pengenalan  
Pendarahan Gastro Usus Atas yang memerlukan endoskopi adalah senario yang selalu 
berlaku di hospital. Namun, bukan semua pesakit memerlukan endoskopi kecemasan atau 
segera. Kajian ini akan mengesahkan dan mengaitkan antara sistem skor Glasgow Blatchford 
dan klasifikasi Forrest. Ia adalah untuk meramalkan tahap Pendarahan Gastro Usus Atas 
Bukan Variceal berdasarkan Skor Glasgow Blatchford dan mengesahkan sistem skor ini di 
Hospital Universiti Sains Malaysia. Kajian ini akan meramalkan kaitan antara dua skor iaitu 
sistem Glasgow Blatchford dan klasifikasi Forrest. Perkaitan antara pendarahan bukan 
variceal risiko tinggi dengan pendarahan major serta bukan pendarahan variceal risiko rendah 
dengan pendarahan minor akan  dikaji. 
Metodologi  
Data dikumpulkan dari Jun 2016 hingga Februari 2017, seramai 113 pesakit dengan 
pendarahan bukan variceal di mana endoskopi kecemasan OGDS telah dikaji secara 
retrospektif dan berstrata berdasarkan skor Glasgow Blatchford kepada risiko tinggi dan 
risiko rendah. Pembahagian kepada risiko telah dikaji dan kaitan bersama klasifikasi Forrest 
untuk menentukan penemuan endoskopi.  
Keputusan  
Jumlah majoriti adalah dalam kumpulan berisiko tinggi seramai 107 (94.7%) pesakit dan 
seramai 6 (5.3%) pesakit adalah kumpulan berisiko rendah. Pesakit yang berada dalam 
kumpulan berisiko rendah telah menunjukkan tiada komplikasi atau kematian selepas 30 hari 
rawatan susulan. Secara kesuluruhannya skor median berdasarkan kajian ini adalah 
10.27±3.54. Berdasarkan data yang dikumpul, skor ini menunjukkan 95.45% sensitiviti dan 
spesifisiti sebanyak 5.49%. Penemuan endoskopi menunjukkan jumlah seramai 22 (19.5%) 
pesakit adalah pendarahan major dan 91 (80.5%) pesakit adalah pendarahan minor. 
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Berdasarkan kajian ini menggunakan Ujian Fisher Exact, tiada kaitan di antara skor Glasgow 
Blatchford dan klasifikasi Forrest (p-value > 0.950).  
Kesimpulan  
Berdasarkan kajian ini, penggunaan Skor Glasgow Blatchford tidak boleh dicadangkan untuk 
digunakan sebagai peramal untuk keterukan dalam Pendarahan Gastro Usus Atas. Ini telah 
dibuktikan dalam keputusan, tiada kaitan di antara Skor Glasgow Blatchford dan Klasifikasi 
Forrest. Namun, keputusan tidak ketara ini disebabkan oleh beberapa factor seperti yang telah 
dibincangkan. Faktor yang berkaitan adalah pesakit menghidapi Penyakit Buah Pinggang 
Kronik dan anemia, waktu endoskopi dilakukan dan perberian ubat. Dengan adanya faktor 
yang telah disahkan, ini boleh dijadikan sebagai bimbingan untuk merangka dan menjalankan 
kajian yang lebih baik pada masa hadapan untuk mendapatkan kesimpulan yang lebih elok 
berkenaan Skor Glasgow Blatchford untuk populasi ini. 
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ABSTRACT 
Introduction  
Upper Gastrointestinal Bleeding (UGIB) requiring endoscopic intervention is a common 
scenario in hospitals. However, not all patients require emergency or urgent endoscopy to be 
done. This study will validate and associate Glasgow-Blatchford Score (GBS) with Forrest 
classification. This is to predict the severity of Non-Variceal Upper Gastro Intestinal Bleed 
according to Glasgow Blatchford Score and validate this scoring system in Hospital 
Universiti Sains Malaysia. This study will also associate between two scoring system of 
Glasgow Blatchford Score and Forrest Classification between Non-variceal high risk 
bleeding with major bleed and non-variceal low risk bleeding with minor bleed.  
Methodology  
Data collected from June 2016 till February 2017, 113 patients with Non-variceal bleed 
underwent emergency OGDS were retrospectively reviewed and were stratified according to 
Glasgow Blatchford Score to high and low risk. This stratified risk is associated with Forrest 
classification to determine its endoscopic findings.  
Results   
Majority are in the high risk group 107 (94.7%) patients and low risk group 6 (5.3%) patients. 
Patients in the low risk group was followed up for 30 days and showed no complications or 
mortality. This study showed patients has a median score of 10.27±3.54. From the data 
analysis of Glasgow Blatchford Score showed 95.45% sensitivity and 5.49% specificity. 
Endoscopic findings showed 22 (19.5%) patients had major bleed and 91 (80.5%) patients 
had minor bleed. Using Fischer Exact Test, there is no significant association between risk 
and outcome (p-value > 0.950).  
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Conclusion   
Based on this study alone, we cannot suggest Glasgow Blatchford Score as a predictor for 
severity of Upper Gastrointestinal Bleeding. This is because as shown in the results, there 
were no significant association between GBS and Forrest classification. However, this 
nonsignificant result maybe compounded by several factors as discussed, namely due to 
underlying Chronic Kidney Disease with anemia, the timing of endoscopy and initiation of 
medication. With this biases identified, it can be used as a guide in designing and conducting 
a better study in the future in order to come to a better conclusion about GBS in our 
population.  
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A. Study Protocol 
 
a. Document submitted for ethical approval 
Introduction and Literature Review 
Upper Gastro-Intestinal Bleed (UGIB) remains a common reason for admission to hospitals all 
over the world (Rockall et al., 1995). The incidence has been reported to range from 50 to 150 
per 100,000 adults per year. It has mortality rates ranging between 8% and 14% in the UK 
(Forrest et al., 1974; Blatchford et al., 2000). Our local Malaysian data shows approximately 72 
per 100,000 had mortality due to UGIB (Malaysia, 2003). However, in this past 50 years, 
hospital mortality due to UGIB has not improved and remains at 10% (Gralnek et al., 2015).  
 
Most patients with UGIB may require OGDS. However, not all patients require emergency or 
urgent endoscopy to be done.  There are many scoring systems that have been created to aid 
clinicians in making decisions. In order to standardize and improve care, various scoring systems 
have been developed to identify individuals at high risk of requiring treatment (Atkinson and 
Hurlstone, 2008). Such scoring system used are Rockall Score (RS), Glasgow-Blatchford Score 
(GBS), Forrest Classification, Cedars-Sinai Medical Centre Predict Index, Baylor College 
Scoring System to name a few. Nowadays, the more widely used pre-endoscopic scoring is the 
RS and GBS. The most common post-endoscopic findings used is the Forrest classification.  
   
Many have compared between these two scoring systems to predict outcomes for better patient 
care. Both of these scores have been widely validated worldwide. For this study, GBS was 
chosen because of many factors. GBS stratifies high risk and low risk patients. Hence, assisting 
clinicians deciding the role of endoscopy as inpatient or outpatient. This scoring system scores 
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patient from 0 to 23. Its criteria consist of urea, hemoglobin level, systolic blood pressure and 
other parameters such as pulse rate, melena at presentation, syncope and history of liver or 
cardiac disease (Table 1). If none of the criteria is met it is considered as score of 0 (Table 2).  It 
uses a cut-off point of ≥1 as high risk and =0 as low risk. It has shown to have identified 99% 
sensitivity with 32% specificity (Blatchford et al., 2000).  
 
Many studies have been done to compare between RS and GBS in predicting patient outcome. 
Stanley et al., 2011 studied about risk scoring systems available. The study was done for 
prediction of clinical end point. It concluded, GBS of zero has been reported to have > 99% 
sensitivity in identification of those who do not require intervention, re-bleed or die in studies 
from Hong Kong, United States, Japan, Taiwan and United Kingdom (Stanley et al., 2011). 
Schiefer et al., 2012 published a paper about predictive validity in GBS in Netherlands. It 
compared the RS, Haemoglobin–Urea–Pulse–Systolic blood pressure (HUPS) with GBS. In 
conclusion, GBS showed to be more superior as compared to the other two scoring system. This 
shows GBS is more accurate than the admission RS for early (pre-endoscopic) prediction of 
clinically relevant outcomes and is highly sensitive in identifying low risk patients suitable for 
out-patient management (Laursen et al., 2012; Schiefer et al., 2012; Bryant et al., 2013; Gralnek 
et al., 2015). 
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Table 1 – Glasgow-Blatchford Score Criteria 
 
 
Table 2 – Glasgow-Blatchford Score of 0 
i.  
ii.  
iii.  
iv.  
 
 
 Hemoglobin level >12.9 g/dL (men) or >11.9 g/dL 
(women) 
 Systolic blood pressure >109 mm Hg 
 Pulse <100/minute 
 Blood urea nitrogen level <6.5 mg/dL 
 No melena or syncope 
 No past or present liver disease or heart failure 
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There has been no validation for GBS in Malaysia and our local hospital population. From 
previous to recent journals, GBS and RS has been widely validated and many studies shows that 
GBS is more superior than RS. Hence, the suggestion to validate GBS in our local hospital. In 
regards, if validation proves to be valid, it can be adapted to our local hospital in the future. This 
will able to predict the need for intervention and hence reduce mortality or morbidity in UGIB 
patients. 
 
By having this scoring system, low risk patients can be safely treated as outpatients. Thus, to 
further improve the possibilities of treating low risk patients, Masaoka et al., 2007 used GBS as a 
guideline but uses a cut-off value of ≥2 as high risk and <2 as low risk. Furthermore, increased 
the number of patient being able to be treated as outpatient with a 100% sensitivity and 13% 
specificity (Masaoka et al., 2007). Srirajakanthan et al., 2010 used a higher cut-off value GBS≥3 
to even include more patients being able to be treated as outpatients. This study had a 100% 
sensitivity and 68% specificity (Srirajaskanthan et al., 2010). Another study by Koksal et al., 
2012 also used a higher cut-off value to calculate the sensitivity and specificity to assess the 
reliability of this score to be used (Koksal et al., 2012).  
 
Adapting this scoring system, Stephens et al., 2009 and McLaughlin et al., 2012 studied 
regarding low risk patient being able to be treated as outpatient are safe. This study was done to 
further evaluate the safety of managing low risk patients as outpatient. Both studies concluded 
that it is safe to treat low risk patients as outpatient (Stephens et al., 2009; McLaughlin et al., 
2012). This is being used as a guideline by the European Society Gastroenterology Endoscopy 
(ESGE) in 2015. 
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Other than pre-endoscopic scoring system, endoscopic findings have been studied and classified. 
Forrest classification uses endoscopic findings to predict risk of re bleeding and mortality. 
Forrest et al., 1974 created a score based on endoscopic findings to stratify risk of re-bleeding. 
Lesions were classified as acutely bleeding, showing evidence of recent bleeding or criteria of 
recent bleeding, showing black base, adherent clot, or a protruding artery or no evidence of 
bleeding (Forrest et al., 1974). High risk lesions include those characterized by spurting 
haemorrhages (Forrest Ia), oozing haemorrhages (Forrest Ib), nonbleeding visible vessels (Forrest 
IIa), adherent clots (Forrest IIb). Low risk lesions include haematin on the ulcer base (Forrest 
IIc), and clean ulcer base (Forrest III). Kim et al., 2009 compared between GBS, RS, Cedars-
Sinai, American Baylor college, Forrest classification and showed Forrest classification was the 
most useful scoring system for the prediction of re-bleeding and death in patients with non-
variceal UGIB. Currently, the Forrest classification is being use as the gold standard for post 
endoscopic findings for risk of re-bleeding (Kim et al., 2009). 
 
It has been proven that high risk patients would require intervention whereas low risk patients 
are able to be treated as outpatient. However, association between pre-endoscopic and post-
endoscopic has never been compared. Hence, the importance of this study to further prove safety 
of patients with high risk would have major bleeding and low risk having minor bleeding. 
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1.2 Rationale of study 
Risk stratification scoring has been used to help and guide clinicians deciding for 
treatment. Many scoring systems has been developed over the years but only a few are being 
used widely. This study will focus on non-variceal upper gastrointestinal bleeding and validate 
GBS in local population and hospital. It will stratify between high risk (>3) and low risk (≤2) 
patients using GBS and associate with endoscopic findings using Forrest Classification. In order 
to be able to treat low risk score patients as outpatient, we need to ascertain that it is a minor 
bleed. Likewise for the high risk score patients, we need to ascertain that it is a major bleed. Low 
risk patients will be able to get an OGDS appointment as outpatient and for high risk patient they 
would require admission with an urgent or early OGDS. Thus, reduce unnecessary admission 
and reduce financial burden of the hospital. 
 
General Objective  
The objective of this study is to stratify Non-Variceal UGIB patients to high and low risk using 
pre-endoscopic parameters and its association with severity of bleeding 
Specific objectives: 
I) Primary objective:  
1. To validate Glasgow Blatchford Score for non-variceal bleeding for local population in 
Hospital Universiti Sains Malaysia (HUSM) 
2. To determine association between non-variceal high risk with major hemorrhage 
(Ia,Ib,IIa or IIb) and low risk with minor hemorrhage (IIc or III) according to GBS and 
Forrest Classification   
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II) Secondary objectives 
1. To review demographics of non-variceal UGIB in HUSM, Kubang Kerian 
 
Design  
Retrospective study of patients with Non-Variceal Upper Gastro Intestinal Bleeding 
Setting 
Hospital Universiti Sains Malaysia 
Study Population 
 
• All patients presented with UGIB requiring OGDS by General Surgery or 
Gastroenterology in HUSM, Kubang Kerian 
 
Source population 
• All patients from Emergency Department and wards presented with UGIB underwent 
OGDS within the same admission by General Surgery Department and Gastroenterology 
in HUSM, Kubang Kerian 
Inclusion criteria: 
 
I. Patients with presentation of UGIB who underwent OGDS in HUSM within the same 
admission from 1st June 2016 till 28th February 2017  
II. OGDS findings of Non-variceal UGIB 
III. UGIB patients that has complete data for GBS (Follow up for 30 days for low risk 
patients) 
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Exclusion criteria: 
 
I. OGDS findings of Variceal UGIB 
II. Patients presented with UGIB but did not undergo OGDS 
III. Patients with incomplete data from records for GBS 
IV. Anemia for investigations without symptoms of UGIB 
V. Patients age below 18 years old 
 
Sampling size  
Two proportions formula is used to obtain the appropriate sample size. The calculation of sample 
size is done by using Power and Sample Size Calculation (PS) Software. The parameters used 
are: 
 
𝛼 = 0.05 
Power = 80% 
𝑃0= proportion of high risk group reported in previous study : 40% 
𝑃1= proportion of high risk group based on expert opinion : 55% 
Ratio 1:5 
Total sample size = 103 
Total sample size including 10% dropout = 113 
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Data collection 
Record of all patients who underwent OGDS for UGIB in HUSM, Kubang Kerian from 
1st June 2016 till 28th February 2017 will be reviewed. This will further follow by ensuring 
patients used for this study will comply to the inclusion and exclusion criteria by reviewing the 
medical records. The study will focus only on non-variceal bleeding. In the process of validation, 
it will score patient and subdivide to high risk and low risk. High risk will further be identified if 
patient requires blood transfusion or surgical intervention. Whereas, the low risk patients will be 
reviewed up till 30 days whether any signs of re-bleeding for which occurred during the same 
admission or patient was readmitted, or mortality related to acute UGIB will be recorded. The 30 
days is taken from the date of OGDS was done. This will be done by reviewing patient medical 
records and if required to contact by phone if no documentation is present.  
To associate between the GBS and Forrest classification, endoscopic findings of major 
and minor hemorrhage with high risk and low risk will be documented. Data retrieved will be 
entered in the data collection form. Subsequently, statistical analysis and report preparation will 
be done. Research correction and admission of final research will be reviewed. 
Data analysis 
 SPSS Statistical software, version 22 will be used for data analysis. 1st and 2nd specific 
objective using univariate analysis Chi-squared test and Fischer Exact Test 
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Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients underwent OGDS for UGIB from 1st 
June 2016 till 28th February 2017 
Patient fulfill inclusion criteria 
Yes No 
Low Risk 
 Correlate with Forrest 
Classification 
 
 
 Blood Transfusion 
 Surgical Intervention 
 High risk 
 Correlate with Forrest 
Classification 
 
Follow up for 30 days 
 No complication 
 Complication 
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B. BODY CONTENT 
a. Introduction 
Upper gastrointestinal bleeding (UGIB) is gastrointestinal bleeding in the upper gastrointestinal 
tract, commonly defined as bleeding arising from the oesophagus, stomach, or duodenum. 
Causes of non-variceal UGIB are due to peptic ulcer, Mallory-Weiss tear, erosive gastritis or 
duodenitis, malignancy, angiodysplasia or vascular malformation. It is known that UGIB remains 
a common reason for admission to hospitals all over the world (Rockall et al., 1995). The 
incidence has been reported to range from 50 to 150 per 100,000 adults per year. It has a 
mortality rates ranging between 8% and 14% in the UK. Our local data shows approximately 72 
per 100,000 in Malaysia (Forrest et al., 1974; Blatchford et al., 2000; Malaysia, 2003). However, 
in this past 50 years, hospital mortality due to UGIB has not improved and remains at 10% 
(Gralnek et al., 2015). 
In order to standardize and improve care, various scoring systems have been developed to 
identify individuals at high risk of requiring treatment (Atkinson and Hurlstone, 2008). Such 
scoring system used are RS, GBS, Forrest Classification, Cedars-Sinai Medical Centre Predict 
Index, Baylor College Scoring System to name a few (Malaysia, 2003). The use of risk scoring 
systems in early assessment of patients suffering from UGIB may be useful to distinguish high-
risks patients, who may need clinical intervention and hospitalization, from low risk patients 
with a lower chance of developing complications, in which management as outpatients can be 
considered (Imperiale et al., 2007). 
 
GBS has been shown to identify patients with suspected UGIB and can be used to predict the 
need for treatment such as blood transfusion, endoscopic therapy or surgical intervention. The 
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greatest feature of the GBS is its ability to identify low-risk patients who do not need to be 
admitted into a hospital (Min et al., 2016). By this, reduces duration of hospital stay and 
admission cost (Girardin et al., 2014; Chatten et al., 2018). Hence, gives a good economical 
outcome for hospital expenses. 
 
Study Objective 
General Objective  
The objective of this study was to predict severity of Non-Variceal UGIB to high risk and low 
risk using pre-endoscopic parameters 
Specific objectives: 
I) Primary objective:  
1. To validate GBS for non-variceal bleeding for local population in HUSM 
2. To associate non-variceal high risk with major hemorrhage (Ia,Ib,IIa or IIb) and low 
risk with minor hemorrhage (IIc or III) according to GBS and Forrest Classification   
II) Secondary objectives 
1. To review demographics of non-variceal UGIB in HUSM, Kubang Kerian 
 
 
 
 
 
21 
 
b. Rationale for Study 
Risk stratification scoring has been used to help and guide clinicians deciding for treatment. 
Many scoring system has been developed over the years but only a few are being used 
widely(Monteiro et al., 2016). This study will focus on non-variceal upper gastrointestinal 
bleeding and validate GBS in local population and hospital. It will stratify and correlate between 
high risk (>3) and low risk (≤2) patients using Glasgow-Blatchford Score with post endoscopic 
findings using Forrest Classification. High risk represents major hemorrhage (Forrest Ia, Ib, IIa, 
IIb) and low risk represents minor hemorrhage (Forrest IIc, III). By stratifying the risk, we are 
able to determine low risk patient and high risk patients. Low risk patients do not need urgent 
OGDS, therefore don’t need admission. Outpatient OGDS appointment may be given, thus, 
reduce unnecessary admission and reduce financial burden and reduce workload of the hospital. 
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c. Methodology 
Design  
Retrospective study of patients with Non-Variceal UGIB 
Study Population 
 
• All patients presented with UGIB requiring OGDS by General Surgery or 
Gastroenterology in Hospital Universiti Sains Malaysia, Kubang Kerian 
 
Source population 
• All patients from Emergency department and wards presented with UGIB underwent 
OGDS within the same admission by General Surgery Department and Gastroenterology 
in HUSM, Kubang Kerian 
Inclusion criteria: 
 
1. Patients with presentation of UGIB who underwent OGDS in HUSM within the same 
admission from 1st June 2016 till 28th February 2017  
2. OGDS findings of Non-Variceal UGIB 
3. UGIB patients that has complete data for GBS (Follow up for 30 days for low risk 
patients) 
Exclusion criteria: 
 
1 OGDS findings of Variceal UGIB 
2 Patients presented with UGIB did not underwent OGDS 
3 Patients with incomplete data from records for GBS 
4 Anemia for investigations without symptoms of UGIB 
5 Patients age below 18 years old 
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Study Design and Data Collection 
 
This study is a retrospective study for all patients which underwent OGDS for UGIB in HUSM, 
Kubang Kerian from 1st June 2016 till 28th February 2017. Patients will comply to the inclusion 
and exclusion criteria by reviewing the medical records. The study will focus only on non-
variceal bleeding. In the process of validation, it will score patient and subdivide to high risk and 
low risk. High risk will further be identified if patient requires blood transfusion or surgical 
intervention. Whereas, the low risk patients will be reviewed up till 30 days whether any signs of 
re-bleeding for which the patient was readmitted, or mortality related to acute UGIB will be 
recorded. The 30 days is taken from the date of OGDS was done. This will be done by reviewing 
patient medical records and if required to contact by phone if no documentation is present. To 
determine the association between GBS and Forrest classification, endoscopic findings of major 
and minor hemorrhage with high risk and low risk will be documented. Data retrieved will be 
entered in the data collection form. Subsequently, statistical analysis and report preparation was 
done.  
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d. Results 
From June 2016 to February 2017, 132 patients underwent emergency OGDS in Hospital 
Universiti Sains Malaysia. 113 patients had non-variceal bleeding and fulfilled the inclusion and 
exclusion criteria. The number of subject that involved in this study fulfilled the calculated 
sample size requirement.  
Demography  
The mean age from our study was 61.75±14.95 (Figure 1).  From the total data collected, 81 
(71.7%) patients were male and 32(28.3%) patients were female (Figure 2). Majority of the 
patient were from Malay ethnicity with 109 (96.5%) patients with 3 (2.65%) patients were 
Chinese and 1(0.85%) patients was a foreigner from Indonesia (Figure 3).  
 
Figure 1: Age Demography in UGIB in HUSM Population 
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